Lipitor to Be Available In Generic Versions From Now On
Submitted by Dinesh Chandra Gaur on Fri, 12/02/2011 - 12:14
It has been revealed in a recent report that the drug firm Ranbaxy has suffered a major setback after Teva, medical firm from Israel, said that they won’t supply the Indian firm with ingredients for the purpose of making copies of Lipitor from the USA.
Ranbaxy Introduces Glaxo's Valacyclovir to American Market
Submitted by Tangaroa Snell on Fri, 11/27/2009 - 06:43
In a new development, medical giant Ranbaxy has taken popular drug Valacyclovir hydrochloride, which is the generic version of GlaxoSmithKline's Valtrex, to markets across US. The pharmaceutical company takes the drug to US on November 25, and it is expected to net nearly $200 Million in revenue during the initial 6 months exclusive period.
